Atopic dermatitis: Clinical and immunologic aspects and treatment: Postgraduate Medicine: Vol 64, No 6

Views

CrossRef citations to date

Altmetric

Abstract

Many of the immunologic abnormalities seen in patients with atopic dermatitis may be explained by beta-adrenergic blockade. On this basis, treatment directed toward increasing the local level of intracellular cyclic adenosine monophosphate should be beneficial. Recent success with caffeine creams supports this view.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Atopic dermatitis

Clinical and immunologic aspects and treatment

Information for

Open access

Opportunities

Help and information

Atopic dermatitis

Clinical and immunologic aspects and treatment

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature